Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Outcome after liver transplantation

Kishore Maganty, David Levi, Jang Moon, Pablo A. Bejarano, Leopoldo Arosemena, Andreas Tzakis, Paul Martin

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma is a rare hepatobiliary malignancy incorporating components derived from both hepatocyte and intrahepatic bile duct epithelium. The natural history, treatment, and prognosis of this distinct cancer differ from hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) and are not completely understood. There is considerable controversy about the classification, treatment, and survival, which in turn is related to the rarity of the condition. Treatment options include surgical resection and the prognosis is believed to be better than CC but worse than HCC alone. Methods: We report a single-center liver transplantation experience with the management of three patients with combined HCC-ICC with LT. Two patients were transplanted with presumed HCC within Milan criteria and the other patient was noted to have an incidental nodule in the explanted liver. Histomorphology and immunohistochemical studies revealed the presence of combined HCC-ICC in all three explants. Results: One patient died 144 days after LT due to metastatic tumor. The second patient is alive and is tumor free at 8.5 years post-LT, and the third patient died of metastatic tumor at 155 days after LT. Conclusion: Good long-term survival can be achieved in at least some patients with this combined tumor type.

Original languageEnglish
Pages (from-to)3597-3601
Number of pages5
JournalDigestive Diseases and Sciences
Volume55
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Cholangiocarcinoma
Liver Transplantation
Hepatocellular Carcinoma
Neoplasms
Intrahepatic Bile Ducts
Survival
Natural History
Hepatocytes
Therapeutics
Epithelium
Liver

Keywords

  • Cholangiocarcinoma
  • Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
  • Hepatocellular carcinoma
  • Liver transplantation

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma : Outcome after liver transplantation. / Maganty, Kishore; Levi, David; Moon, Jang; Bejarano, Pablo A.; Arosemena, Leopoldo; Tzakis, Andreas; Martin, Paul.

In: Digestive Diseases and Sciences, Vol. 55, No. 12, 01.12.2010, p. 3597-3601.

Research output: Contribution to journalArticle

Maganty, Kishore ; Levi, David ; Moon, Jang ; Bejarano, Pablo A. ; Arosemena, Leopoldo ; Tzakis, Andreas ; Martin, Paul. / Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma : Outcome after liver transplantation. In: Digestive Diseases and Sciences. 2010 ; Vol. 55, No. 12. pp. 3597-3601.
@article{915e71d8f8004a21b3208caff4d0c662,
title = "Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Outcome after liver transplantation",
abstract = "Background: Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma is a rare hepatobiliary malignancy incorporating components derived from both hepatocyte and intrahepatic bile duct epithelium. The natural history, treatment, and prognosis of this distinct cancer differ from hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) and are not completely understood. There is considerable controversy about the classification, treatment, and survival, which in turn is related to the rarity of the condition. Treatment options include surgical resection and the prognosis is believed to be better than CC but worse than HCC alone. Methods: We report a single-center liver transplantation experience with the management of three patients with combined HCC-ICC with LT. Two patients were transplanted with presumed HCC within Milan criteria and the other patient was noted to have an incidental nodule in the explanted liver. Histomorphology and immunohistochemical studies revealed the presence of combined HCC-ICC in all three explants. Results: One patient died 144 days after LT due to metastatic tumor. The second patient is alive and is tumor free at 8.5 years post-LT, and the third patient died of metastatic tumor at 155 days after LT. Conclusion: Good long-term survival can be achieved in at least some patients with this combined tumor type.",
keywords = "Cholangiocarcinoma, Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma, Hepatocellular carcinoma, Liver transplantation",
author = "Kishore Maganty and David Levi and Jang Moon and Bejarano, {Pablo A.} and Leopoldo Arosemena and Andreas Tzakis and Paul Martin",
year = "2010",
month = "12",
day = "1",
doi = "10.1007/s10620-010-1402-3",
language = "English",
volume = "55",
pages = "3597--3601",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Plenum Publishers",
number = "12",

}

TY - JOUR

T1 - Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma

T2 - Outcome after liver transplantation

AU - Maganty, Kishore

AU - Levi, David

AU - Moon, Jang

AU - Bejarano, Pablo A.

AU - Arosemena, Leopoldo

AU - Tzakis, Andreas

AU - Martin, Paul

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Background: Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma is a rare hepatobiliary malignancy incorporating components derived from both hepatocyte and intrahepatic bile duct epithelium. The natural history, treatment, and prognosis of this distinct cancer differ from hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) and are not completely understood. There is considerable controversy about the classification, treatment, and survival, which in turn is related to the rarity of the condition. Treatment options include surgical resection and the prognosis is believed to be better than CC but worse than HCC alone. Methods: We report a single-center liver transplantation experience with the management of three patients with combined HCC-ICC with LT. Two patients were transplanted with presumed HCC within Milan criteria and the other patient was noted to have an incidental nodule in the explanted liver. Histomorphology and immunohistochemical studies revealed the presence of combined HCC-ICC in all three explants. Results: One patient died 144 days after LT due to metastatic tumor. The second patient is alive and is tumor free at 8.5 years post-LT, and the third patient died of metastatic tumor at 155 days after LT. Conclusion: Good long-term survival can be achieved in at least some patients with this combined tumor type.

AB - Background: Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma is a rare hepatobiliary malignancy incorporating components derived from both hepatocyte and intrahepatic bile duct epithelium. The natural history, treatment, and prognosis of this distinct cancer differ from hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) and are not completely understood. There is considerable controversy about the classification, treatment, and survival, which in turn is related to the rarity of the condition. Treatment options include surgical resection and the prognosis is believed to be better than CC but worse than HCC alone. Methods: We report a single-center liver transplantation experience with the management of three patients with combined HCC-ICC with LT. Two patients were transplanted with presumed HCC within Milan criteria and the other patient was noted to have an incidental nodule in the explanted liver. Histomorphology and immunohistochemical studies revealed the presence of combined HCC-ICC in all three explants. Results: One patient died 144 days after LT due to metastatic tumor. The second patient is alive and is tumor free at 8.5 years post-LT, and the third patient died of metastatic tumor at 155 days after LT. Conclusion: Good long-term survival can be achieved in at least some patients with this combined tumor type.

KW - Cholangiocarcinoma

KW - Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma

KW - Hepatocellular carcinoma

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=78649330024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649330024&partnerID=8YFLogxK

U2 - 10.1007/s10620-010-1402-3

DO - 10.1007/s10620-010-1402-3

M3 - Article

VL - 55

SP - 3597

EP - 3601

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 12

ER -